In reply.
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
James
J
Yao
Diane
D
Reidy Lagunes
Matthew H
MH
Kulke
D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D018358:Neuroendocrine Tumors / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic